Navigating Challenges in Drug Discovery with Dr. Alfred Botchway

Navigating Challenges in Drug Discovery with Dr. Alfred Botchway

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Alfred Botchway, CEO of Attentive Science, to discuss his journey in biomedical science and the groundbreaking work being done at the intersection of AI, non-clinical safety, and drug discovery. Dr. Botchway shares his insights on the role of AI in refining toxicology studies, how stress impacts human health, and his experience founding companies like Xenometrics and Attentive Science.

The conversation dives deep into the complexities of Good Laboratory Practices (GLP), the importance of regulatory standards, and the exciting research happening in anxiety and PTSD treatments. Dr. Botchway also discusses the future of biomedical research, the need for greater collaboration between academia and industry, and how innovations in sample collection are transforming clinical trials.

Whether you’re interested in AI, biomedical innovation, or the future of drug discovery, this episode offers valuable insights from a leader shaping the industry.

Don’t forget to subscribe and let us know your thoughts in the comments below!

Dr. Alfred Botchway

https://www.linkedin.com/in/alfred-botchway-41b01a6/

CEO of Attentive Science: https://www.attentivescience.com/

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

Celerion - https://www.celerion.com/


00:00 Introduction to BioTalk Unzipped

02:32 Dr. Alfred Botchway's Journey in Biomedical Science

03:48 Challenges Founding and Growing Xenometrics

07:30 Starting Attentive Science: A New Venture

09:37 Love of the Work - Variations

10:26 The Role of AI in Non-Clinical Safety Assessments

13:04 The Three Rs: Replace, Reduce, Refine, and AI

15:46 Regulatory Standards and Good Laboratory Practices

20:42 New News! - Research on Anxiety and Drug Discovery

27:07 Cortical Stimulation and Stress Management

27:45 Bridging Academia and Industry

29:26 Engaging the Next Generation in Science

32:42 The Value of Vocational Training in Science

34:47 Community Involvement and Giving Back

37:00 Cultural Influences on Leadership

42:39 Global Expansion and Strategic Goals

48:41 Innovations in Sample Collection for Clinical Trials


Digital Twin Episodes reference with Tomas Helikar:

Transforming Immunology: The Promise of Digital Twins with Dr. Tomáš Helikar

https://youtu.be/jTM_Zlt3wxU


Digital Twins: The Future of Drug Discovery with Dr. Tomáš Helikar

https://youtu.be/NM5X0jTd6UA

Episoder(41)

How AI is Helping Diagnose Disease with Chuck Piccirillo

How AI is Helping Diagnose Disease with Chuck Piccirillo

Summary In this conversation, Gregory Austin and Chad Briscoe interview Chuck Piccirillo, CEO of Zealic Health, about his experience in the healthcare industry and the focus on patient-centric soluti...

2 Aug 202438min

Reptiles, Treatments, and Cell-Gene Therapy with Dr. Vick

Reptiles, Treatments, and Cell-Gene Therapy with Dr. Vick

Summary Dr. Andy Vick shares some of the things that surprised him throughout his career and he discusses his passion for reptiles and his experience discussing the pharmaceutical potential of venom w...

15 Jul 202438min

Amyloidosis Exposed: New Hope with Dr. Vick

Amyloidosis Exposed: New Hope with Dr. Vick

Summary Dr. Andy Vick discusses his work at Attralus Therapeutics, a biotech company focused on developing treatments for systemic amyloidosis. He explains the etiology of the disease and how Attralus...

1 Jul 202440min

A Diagnostic Breakthrough for Alzheimer’s with Dr. Jonathon Hill

A Diagnostic Breakthrough for Alzheimer’s with Dr. Jonathon Hill

A Diagnostic Breakthrough for Alzheimer’s Summary In this conversation, Dr. Jonathan Hill discusses his work in nanopore sequencing-based technology and its applications in genetic and epigenetic rese...

1 Jun 202430min

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke Summary In Episode 13, Jason Burke discusses the unique approach of the Duke program in providing real-world healthcare data...

15 Mai 202435min

Unlocking the Future of Healthcare with Organoids, AI, and Quantum Computing with Jason Burke

Unlocking the Future of Healthcare with Organoids, AI, and Quantum Computing with Jason Burke

Summary In this episode of BioTalk Unzipped, the hosts discuss the applications and ethical concerns surrounding organoids, which are 3D cell clusters that mimic the features of full-sized organs. The...

1 Mai 202434min

Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner

Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner

Summary In this episode, Scott Schliebner discusses the unique challenges and complexities of rare disease trials. He highlights the difficulties in recruiting patients, the multidisciplinary nature o...

15 Apr 202436min

Impact of AI in Rare Disease Trials with Scott Schliebner

Impact of AI in Rare Disease Trials with Scott Schliebner

Impact of AI in Rare Disease Trials with Scott Schliebner Summary In this episode, the hosts welcome Scott Schliebner as their guest and kick off with a charitable act, donating to Rare Givers. They d...

1 Apr 202436min

Populært innen Business og økonomi

lydartikler-fra-aftenposten
stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
pengepodden-2
finansredaksjonen
utbytte
livet-pa-veien-med-jan-erik-larssen
pengesnakk
stormkast-med-valebrokk-stordalen
okonomiamatorene
morgenkaffen-med-finansavisen
liberal-halvtime
tid-er-penger-en-podcast-med-peter-warren
rss-politisk-preik
lederpodden
rss-pa-konto
rss-fa-makro